Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS® for oral suspension, a new pediatric formulation of Merck's integrase ...
Tags: Merck, ISENTRESS®, oral suspension, pediatric formulation
Warner Chilcott has announced US FDA approval of norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, new oral contraceptive. The company expects to make the product available in early August 2013. ...
Lupin Pharmaceuticals has obtained FDA approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL and anticipates initiating product shipment shortly. Suprax oral suspension is indicated for otitis media, acute exacerbation of chronic ...
Tags: Lupin Pharmaceuticals, FDA, Suprax
Mylan's subsidiary Mylan Pharmaceuticals has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Phenytoin Chewable Tablets USP, 50 mg. Phenytoin is the generic ...
Tags: Mylan, Mylan Pharmaceuticals, US, FDA, ANDA, Phenytoin Chewable Tablets
Qualitest Pharmaceuticals has introduced generic version of Singulair (montelukast sodium) tablets and chewable tablets and will immediately begin the product shipment. The launch of the Montelukast Sodium Tablets indicated for treating ...
Tags: Generic Singulair Tablets, Chewable Tablets, Endo Health Solutions